A gap in science-backed skincare products in the Indian market prompted Shaily Mehrotra to start Fixderma, with an aim to solve common skin...

As global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...

The agriculture industry has evolved historically through adaptation and resilience, and now it is time to speed up this transformation, em...

Scientists are exploring a new way to treat chronic nerve pain by focusing on mitochondria, the energy-producing parts of cells. Researcher...

Novartis India country president and managing director Amitabh Dube said India is gradually moving beyond its traditional role as a clinica...

HAB Pharma and Signature Phytochemicals have merged, creating a consolidated entity with a turnover of Rs600 crore. This strategic move aim...

Hong Kong's stock market is seeing more foreign companies file for listings. Firms from countries like Indonesia and South Korea are explor...

Metropolis Healthcare is set for its next growth phase. The diagnostic chain will focus on genomics and specialty diagnostics. Strategic ac...

Zydus is acquiring US-based Assertio Holdings for $166.40 million to bolster its specialty oncology presence in the US. The deal, structure...

In a bold move that positions Zydus at the forefront of the U.S. specialty oncology market, the Indian drug manufacturer has secured a $166...

Quote of the day by American psychologist Carl Rogers: Carl Rogers believed that one of the most powerful human experiences is simply being...

Biocon is shifting its strategy to focus on capacity utilization, margin expansion, and improved returns after significant investments in g...

Two new educational programs are being introduced to support this goal. These programs are designed to equip professionals with the skills ...

Australian authorities are preparing for the arrival of ISIS-linked women and children. The Australian Federal Police has a plan for monito...

Biocon's founder Kiran Mazumdar-Shaw has made a groundbreaking announcement, pledging her niece Claire Mazumdar as her heir apparent. The t...

Kiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...

Biocon founder Kiran Mazumdar-Shaw has named her niece, Claire Mazumdar, as her successor. Claire Mazumdar, a successful CEO of Bicara Ther...